Association of β-Blocker Therapy at Discharge with Clinical Outcomes after Acute Coronary Syndrome in Patients without Heart Failure

AIM: To evaluate the clinical impact of β-blocker in patients with adequate left ventricular ejection function (LVEF) who underwent percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). METHODS: A total of 10,724 consecutive patients who underwent PCI throughout 2013 were prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yan, Tang, Xiao-fang, Gao, Run-lin, Yang, Yue-jin, Xu, Bo, Yuan, Jin-qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196986/
https://www.ncbi.nlm.nih.gov/pubmed/32405323
http://dx.doi.org/10.1155/2020/4351469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196986/
https://www.ncbi.nlm.nih.gov/pubmed/32405323
http://dx.doi.org/10.1155/2020/4351469

Ejemplares similares